Epidemiologic studies have previously reported an association between high fat intake and colon cancer risk. However, findings have generally been inconclusive. This study aimed to investigate the association between fat as a percentage of energy intake and colon cancer risk. Study subjects included 215 cases and 215 matched controls identified by the Defense Medical Surveillance System. Percentage energy from fat (Pfat) was estimated using a short dietary screener developed by the National Cancer Institute for two time periods: the year before the first blood draw and the year before colon cancer diagnosis. Conditional logistic regression analysis was used to assess the relationship between colon cancer risk and Pfat. Odds ratios and 95% confidence intervals (CIs) were calculated. Compared with the lowest quartile of Pfat, the adjusted odds of having colon cancer were 2.00 (95% CI 0.96-4.18), 2.83 (95% CI 1.41-5.66), and 3.37 (95% CI 1.58-7.17), respectively, for the second, third, and highest quartiles in the year before cancer diagnosis. Similar results were observed for Pfat at an earlier time point. Our findings suggest a positive association between Pfat and colon cancer in the US military population.
Introduction
Experimental studies have shown that dietary fat intake increases the risk of colorectal cancer by increasing secretion of secondary bile acids, which can promote cell proliferation (Nigro et al., 1973; Chomchai et al., 1974; Narisawa et al., 1974; Lapre and Van der Meer, 1992; Park et al., 2012; Tang et al., 2012) , alter intestinal microflora (Reddy and Wynder, 1973; Kim et al., 2012) , and damage colonic membranes (Vahouny et al., 1984; Rafter et al., 1986; Nagengast et al., 1995) . Although many epidemiologic studies have investigated the relationship between dietary fat and colorectal cancer (Kushi and Giovannucci, 2002; Vargas and Thompson, 2012) , results have been inconsistent.
A pooled analysis of 13 case-control studies found no evidence of any energy-independent effects of total fat and colorectal cancer risk (Howe et al., 1997) . In a metaanalysis of six prospective cohort studies on the relationship between animal fat consumption and colorectal cancer (Alexander et al., 2009) , four observed null associations (Bostick et al., 1994; Goldbohm et al., 1994; Lin et al., 2004; Sanjoaquin et al., 2004) and two reported elevated risk with increased animal fat intake (Willett et al., 1990; Giovannucci et al., 1994) . In the Nurses' Health Study (Willett et al., 1990) , highest versus lowest intake of total or animal fat was positively associated with colon cancer after adjusting for total energy intake. A relative risk of 2.00 for total and 1.89 for animal fat was observed when comparing highest versus lowest consumption of fat (Willett et al., 1990) . In addition to the studies included in the meta-analyses, some studies (West et al., 1989; Whittemore et al., 1990) have shown increased risk associated with high fat consumption, whereas others have shown no association (Dahm et al., 2010; Sun et al., 2012) . Similar to studies on total dietary and animal fat intake, results from studies that evaluated specific fat constituents are also not entirely clear. Whereas many reported null associations (Stemmermann et al., 1984; Giovannucci et al., 1994; Goldbohm et al., 1994; Lin et al., 2004; Dahm et al., 2010; Zhong et al., 2013) , some observed positive associations with saturated (Whittemore et al., 1990; Willett et al., 1990) and monounsaturated (Willett et al., 1990) fats and others reported inverse associations with polyunsaturated fat (Howe et al., 1997; Levi et al., 2002; Theodoratou et al., 2007; Williams et al., 2010) .
Despite the inconsistency in research, a comprehensive review by the World Cancer Research Fund/American Institute for Cancer Research (2007) reported that there is limited evidence that foods containing animal fat increase colorectal cancer risk. Thus, current federal dietary guidelines recommend between 20 and 35% of energy intake from fat for adults (Institute of Medicine, 2002; US Department of Agriculture and US Department of Health and Human Services, 2010). Percentage energy from fat (Pfat) reflects the amount of fat consumed relative to total energy intake. A high Pfat (>35%) generally relates to increased consumption of saturated fat (US Department of Agriculture and the US Department of Health and Human Services, 2005) . However, research on Pfat in relation to colorectal cancer risk is sparse and results have been inconsistent. Null (Flood et al., 2003; Lin et al., 2004; Williams et al., 2010; Sun et al., 2012) , positive (West et al., 1989) , and inverse (Stemmermann et al., 1984) associations between Pfat and colorectal cancer risk have all been reported.
Previous studies on Pfat included both colon and rectal cancers. If the relationship between Pfat and risk differs between colon and rectal cancers, association with a specific site might be diluted. In addition, although Pfat at diagnosis was usually used in these studies, Pfat at an earlier time point may be more important for etiologic research because of a long latent period of cancer occurrence. This study aimed to assess the relationship between Pfat and colon cancer risk in the US military population. We investigated Pfat in the year before diagnosis and earlier in life.
Methods

Study participants
We conducted a case-control study among US activeduty military members. Study participants were identified through the Defense Medical Surveillance System (DMSS). DMSS hosts a central repository of longitudinal medical data for all active-duty members and the Department of Defense Serum Repository that collects blood samples from all members approximately every other year (Rubertone and Brundage, 2002) . This study was approved by the Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center Institutional Review Boards.
Eligible cases included men and women diagnosed with colon cancer between 1 January 2001 and 31 December 2009, who were between 17 and 79 years of age at diagnosis of colon cancer, were on active duty at time of diagnosis, and had at least one prediagnostic serum sample of 1 ml or more. We used a lower age bound of 17 years because that is the minimum age for entry into the US military and an upper age bound of 79 years to minimize incorrect recall of information. Serum samples were a study criterion because the original purpose of this study was to identify serum biomarkers. Controls were men and women who did not have colon cancer, were on active duty during the reference year (corresponding to the diagnosis year of the matched case), had at least one serum sample of 1 ml or more, and were alive at the beginning of the study. They were matched to cases in terms of sex, age (within 1 year of birth), racial background (European-American, African-American, and other), and time points at which serum samples were collected (within 60 days of the requested case sample).
At the first step of study participant enrollment, DMSS identified and provided a list of all eligible cases according to the International Classification of Diseases-9th revision (ICD-9) coding system. Before contacting the eligible cases, we verified survival status through the Defense Manpower Data Center, which manages and updates all personnel information, as well as the CDC's National Death Index and the Social Security Administration. An informative letter describing the study purpose and procedures, the informed consent document, and a questionnaire packet were mailed to all the surviving cases. After 3 weeks, participants who provided no response or incomplete information were followed up with reminder emails, phone calls, or letters. For each case who participated, a matched control was contacted using procedures similar to that for case recruitment. Five potential controls were identified and were randomly selected by DMSS on the basis of matching criteria. If the person did not respond or did not want to participate, the next control was contacted until successful enrollment.
There were 593 eligible colon cancer cases after excluding individuals who reported that they did not have the disease. Of these individuals, 138 were unreachable and 162 were deceased. Of the remaining 293 cases who responded, 234 participated (82%). We then contacted 532 controls who were matched to cases according to the procedures described above. Of the contacted controls, five were deceased and 162 were unreachable or did not respond. Of the remaining 365 controls, 215 ultimately participated (59%). A matched control was successfully recruited for 92% (215/234) of the participating cases. Informed consent was obtained from all eligible study participants.
Data collection
Self-administered questionnaires were utilized to collect epidemiologic data. Telephone interviews were conducted for those who preferred to provide information over the phone (cases, N = 23; controls, N = 12). Epidemiologic data included demographic variables, personal habits and lifestyle characteristics, medical history, personal feelings and health, family histories of cancer and colorectal polyps, menstrual/contraceptive /reproductive histories (for women only), and dietary intake. When applicable, questions on risk factor exposures at the time before first blood draw for military duty (time 1) and in the year before cancer diagnosis for cases or reference date for controls (time 2) were asked. These data allowed us to assess risk factors at both time points. The mean length of time between the two time periods was 10.4 years, which did not significantly differ between cases and controls.
Information on fat intake was collected using a validated Short Percentage Energy from Fat Screener developed by the National Cancer Institute (NCI; Applied Research Program National Cancer Institute, 1996), which consisted of 16 questions on the frequency of usual consumption for 15 food groups and on the use of reducedfat margarine (Thompson et al., 2007) . Detailed information on food items included in the screener can be found at http://riskfactor.cancer.gov/diet/screeners/fat. At time 2, frequency was designated using eight possible response categories that ranged from 'never' to 'two or more times per day'. For time 1, possible responses included 'lower', 'same', or 'higher' consumption at time 1 compared with time 2 for the same 16 questions.
Additional tumor and clinical characteristics were obtained from the Automated Central Tumor Registry (ACTUR), the DoD cancer registry. Among the 234 cases, information was available for 182. Although all participating cases understood that this was a colon cancer study, a colon cancer diagnosis was documented in the cancer registry only for 135 cases.
Statistical analysis
We first described the distribution of demographic variables by case-control status and then compared Pfat of cases and controls at time 1 and time 2, separately. Pfat was estimated using SAS programs developed by NCI (Applied Research Program National Cancer Institute, National Institutes of Health, 1996) . For time 2, agespecific/sex-specific portion sizes were determined through dietary intake data from the USA using the US Department of Agriculture's 1989-91 Continuing Survey of Food Intakes by Individuals (CSFII) (US Department of Agriculture, 1996) . Portion-size information and sexspecific regression coefficients relating Pfat and each food group were subsequently applied to participant responses on frequency of consumption. Pfat was then calculated on the basis of these measures from all food items. For time 1, we developed a scoring procedure to quantify responses into a measure of relative intake based on participant responses from time 2. For each food item, responses at time 1 (lower = 1, same = 2, and higher = 3) were multiplied by each of the 16 responses at time 2. These measures were subsequently combined with age-specific/sex-specific portion sizes and sexspecific regression coefficients according to NCI procedures. A relative Pfat score was then obtained on the basis of all food items.
In data analysis, Pfat was categorized into quartiles based on the distribution of controls, separately for time 1 and time 2. We defined the lowest and highest consumers of total fat as a percentage of energy to be in the first (Q1) and fourth (Q4) quartiles, respectively. Pfat was assessed as both continuous and categorical variables.
Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using conditional logistic regression analysis to assess the relationship between Pfat and colon cancer. In unadjusted analyses, results were further stratified by sex to account for potential differences in dietary fat intake. The following potential confounders were considered for inclusion in our multivariate models: race/ethnicity, highest education, service branch, marital status, religion, household income, number of people living in the household, personal history of colon and rectal polyps, family history of cancer, physical activity, history of alcohol, history of smoking, deployment status, BMI [classified according to World Health Organization (2014)], other health conditions (family polyposis, ulcerative colitis/Crohn's disease, duodenal ulcer, stomach ulcer, gallstone disease, lactose intolerance, diabetes mellitus, hypertension, coronary artery disease, and pancreatitis), and medications (NSAIDS and aspirin). The combined race-ethnicity covariate was considered as a potential confounder, although race (not ethnicity) was one of the matching factors. Covariates that altered the OR of Pfat by 10% or higher for time 1 or time 2 were selected as potential confounders and included in the multivariate models. These covariates were smoking status, ever drinker, service branch, and deployment status. As we collected data for two time periods, variables at corresponding time points were respectively used in the models. To confirm the results, we repeated multivariate analyses using cases with confirmed colon cancer according to both DMSS and ACTUR, and their matched controls. P-values for trend were also calculated. Multivariate analysis stratified by sex was not possible because of the small number of female participants.
All statistical analyses were carried out using SAS version 9.3 (SAS Institute, Cary, North Carolina, USA). We defined statistical significance at P less than 0.05.
Results
In the present study, the average age was about 41 years and the proportion of male participants was 82.3% for both cases and controls. Table 1 presents the distribution of selected demographic characteristics at time 2 by case-control status. Cases and controls were similar across all demographic variables except for service branch, for which cases were more likely to be in the Air Force (26.1%) and less likely to be in the Navy (30.2%) compared with controls. Table 2 shows the relationship between Pfat and colon cancer risk by time and sex. At time 1, individuals in the second highest (Q3) and highest (Q4) quartiles of Pfat had a higher odds of colon cancer (Q3: OR 2.42; CI 1.31, 4.48 and Q4: OR 1.96; CI 1.03, 3.71) compared with those in the lowest quartile (Q1). Similar results were observed at time 2 for Q3 (OR 2.18; CI 1.24, 3.83) and Q4 (OR 1.91; CI 1.05, 3.46). In addition, risk was found to increase with Pfat at time 1 (P trend = 0.029) and time 2 (P trend = 0.007). When data were stratified by sex, corresponding ORs (Q4 vs. Q1) and P-values for trend were 9.06 (CI 1.57, 52.23) and 0.010 at time 1 and 7.35 (CI 1.17, 46 .12) and 0.009 at time 2 for female individuals. Among male individuals, we observed increased risk; however, none was significant.
After adjusting for smoking, alcohol, deployment, and service branch (Table 3) , individuals in Q3 and Q4 had a higher odds of colon cancer compared with those in Q1 at time 1 (Q3: OR 2.54; CI 1.18, 5.46 and Q4: OR 3.08; CI 1.33, 7.11) and time 2 (Q3: OR 2.83; CI 1.41, 5.66 and Q4: OR 3.37; CI 1.58, 7.17). P-values for trend were 0.007 at time 1 and 0.001 at time 2, respectively. When analyses were confined to cases with confirmed colon cancer in both DMSS and ACTUR databases and their matched controls, the direction and magnitude of the ORs were similar at time 1 and time 2.
Discussion
Our study found that Pfat both in the year before cancer diagnosis and in the year before first blood draw was associated with increased colon cancer risk. Compared with individuals with the lowest percentage of energy intake from fat, those with higher intake at diagnosis (>31.8% Pfat) and at an earlier time point had a significantly increased risk of colon cancer. These associations might exist primarily among female individuals.
Although there are few studies on Pfat in relation to colon cancer, results from previous case-control studies on fat intake have not been consistent. An OR of 2.0 (CI 1.0-4.0) for male individuals and 1.9 (CI 1.0-3.7) for female individuals was observed when comparing highest versus lowest fat intake in a colon cancer study conducted in Utah (West et al., 1989) . In addition, a matched case-control study on colon and rectal cancers in Chinese Americans located in North America showed an OR of 1.8 (CI 1.3-2.5) for male individuals and 2.0 (CI 1.2-3.5) for female individuals from saturated fat (Whittemore et al., 1990) . In contrast, a combined analysis of 13 case-control studies did not report any associations with total fat or fat constituents (Howe et al., 1997) . Among cohort studies, both positive (Willett et al., 1990; Giovannucci et al., 1994) and null (Lin et al., 2004; Dahm et al., 2010; Sun et al., 2012) associations of total fat and colon cancer have been reported. Although the differences in results may be due to variability in measurement of fat intake and fat source and may depend on whether specific fat constituents were considered, baseline study design and population may be important related factors.
In this study, we used another measurement of fat intake (Pfat) to assess its relationship with colon cancer risk and observed a more than a three-fold increase in risk among the highest consumers of fat. Pfat reflects the relative intake of total fat and is positively related to the consumption of saturated fat (US Department of Agriculture and the US Department of Health and Human Services, 2005). Although we were unable to specify individual fat constituents, we provided some insight into whether total fat or saturated fat intake may be related to colon cancer risk. Further, many studies assessed fat intake on the basis of time at cancer diagnosis for cases and the corresponding reference date for controls (Potter and McMichael, 1986; West et al., 1989; Whittemore et al., 1990; Sun et al., 2012) . Because of a long latent period for cancer occurrence, exposure at an earlier time point is a desired measurement. Results from our study suggest that Pfat is positively associated with colon cancer not only at cancer diagnosis but also at an earlier time point (average of 10 years earlier).
When data were stratified by sex, the difference in Pfat between cases and controls seemed to be primarily driven by the female sex. Because we were not able to carry out multivariable analyses by sex owing to small sample size, our results are only suggestive of the possible effects of sex. This finding is supported by positive associations previously reported in an all-female cohort (Willett et al., 1990) , as well as in case-control studies (Potter and McMichael, 1986; West et al., 1989; Whittemore et al., 1990) on fat intake and colon cancer. Although it is not clear why the association exists primarily among women in our study, recent literature suggests that this may be related to estrogen profiles, which may increase colon cancer risk (Liang, 2007) . Animal models have shown that high-fat diets may downregulate estrogen receptors in adipose tissue, which subsequently increases inflammation and insulin resistance while decreasing glucose metabolism (Giovannucci, 2001; Riant et al., 2009; Purim et al., 2013 )all of which are associated with an increased risk of carcinogenesis.
Although our study is the first of its kind that measures the percentage of energy intake from fat at two time points and assesses its relation with colon cancer risk, it has its limitations. The number of study participants is relatively small overall, which prevented us from carrying out multivariate analysis by sex. Like many other studies, there may be errors in recalling dietary intake. If errors are differential between cases and controls, the results might be biased. In addition, the participation rates were relatively low and varied between cases and controls. We cannot exclude the possibility that differential participation may have affected the results. The Pfat screener is a short dietary screener intended for broad comparisons of fat intake and is, thus, limited in its ability to assess detailed dietary information accurately. Further, the Pfat score at time 1 is a weighted relative measure, rather than a direct measure based on reported frequencies of food consumption. Thus, it is not as accurate as the measure at time 2. Finally, the study participants were active-duty members, who may differ from the general population in many aspects including dietary intake and physical activity; therefore, our results may not be readily generalizable.
In summary, these data suggest that increased fat consumption as a percentage of total energy intake is associated with increased colon cancer risk at both cancer diagnosis and at an earlier time point, which may be mainly observed among female individuals. Confirmation in a larger study is warranted.
